Behavioral Safety and Fentanyl Education: BSAFE
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSan Francisco Department of Public Health
About this trial
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.
Eligibility criteria
Qualifiers
Aged 18 years or older,
Reports intentional cocaine or methamphetamine use >15 of past 30 days,
Urine positive for cocaine or methamphetamine and negative for opioids/fentanyl prior to enrollment
Be able to provide the names of at least 2 persons who can consistently locate their whereabouts.
Disqualifiers
Reports past 30-day intentional use of any opioid or ongoing use of an opioid antagonist (e.g., naltrexone)
Intends to leave area in coming year,
Unable to communicate in English or Spanish,
Any other condition that, in the PI's judgment, interferes with safe study participation or adherence to study procedures.
Trial design
Treatments tested in this trial
- BSAFE Intervention
- Attention control
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
San Francisco Department of Public Health
Lead sponsor
University of California, San Francisco
Collaborator
Source ClinicalTrials.gov